PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsneoplasms
MeSH D009369 - neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009369: 
Neoplasms
$
Success rate
D003560:Cysts
0 Companies
0 Drugs
Success rate
D006222:Hamartoma
0 Companies
0 Drugs
Success rate
D009370:Neoplasms by histologic type
0 Companies
0 Drugs
Success rate
D009371:Neoplasms by site
0 Companies
0 Drugs
Success rate
D009374:Experimental neoplasms
0 Companies
0 Drugs
Success rate
D009376:Hormone-dependent neoplasms
$
Success rate
D009378:Multiple primary neoplasms
0 Companies
0 Drugs
Success rate
D009381:Radiation-induced neoplasms
0 Companies
0 Drugs
Success rate
D009385:Neoplastic processes
$
Success rate
D009386:Hereditary neoplastic syndromes
0 Companies
0 Drugs
Success rate
D010257:Paraneoplastic syndromes
$
Success rate
D011230:Precancerous conditions
0 Companies
0 Drugs
Success rate
D011252:Neoplastic pregnancy complications
0 Companies
0 Drugs
Success rate
D016609:Second primary neoplasms
0 Companies
0 Drugs
Success rate
D017169:Post-traumatic neoplasms
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaEpoetin theta Biopoin  2009-10-23   
Fentanyl Effentora  2008-04-04   
Filgrastim Tevagrastim  2008-09-15   
Zoledronic acid Zoledronic acid Teva  2012-08-16   
RocheIbandronic acid Destara  1996-06-25   
Epoetin beta NeoRecormon  1997-07-16   
Entrectinib Rozlytrek  2020-07-31 $26.653 M Y2020 
SandozFilgrastim Zarzio  2009-02-06   
Merck & CoAprepitant Emend  2003-11-11 $145 M Y2020 
Fosaprepitant Ivemend  2008-01-11   
PfizerFilgrastim Nivestim  2010-06-07   
Palonosetron Palonosetron Hospira  2016-04-08   
Epoetin zeta Retacrit  2007-12-18 $340 M Y2023 
TakedaFentanyl Instanyl  2009-07-20   
Bristol Myers SquibbIdecabtagene vicleucel Abecma  2021-08-18 $401 M Q4/23-Q3/24 
Accord HealthcarePalonosetron Palonosetron Accord  2016-05-26   
Zoledronic acid Zoledronic Acid Accord  2014-01-16   
Kyowa KirinFentanyl PecFent  2010-08-31   
Granisetron Sancuso  2012-04-20   
1
2
3
>
Clinical Trials
Historical Success Rate
Phase 1
72%
473/656
Phase 2
42%
255/604
Phase 3
32%
108/336
Approved: 21Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Sandoz
Merck & Co
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use